Experts believe hiking prices could be Chinese response to the Modi government’s Profit Linked Incentive scheme, which seeks to achieve self-dependence in API production.
Dr Dilip Mahalanabis pioneered the use of ORS in refugee camps — a solution that has saved millions and been called the most important medical advance of the 20th century.
In 'Caring For Life: The Cipla Story Since 1935', Tulsi Vatsal writes about how Khwaja Abdul Hamied wanted to create a science-based industry for India.
The Nobel Assembly said the 3 scientists have made a decisive contribution as the disease can now be cured for the first time in history, raising hopes of eradicating it.
In Pharma, Gerald Posner writes about how an unlikely trio working for a small US company called Lederle discovered Aureomycin, a broad-spectrum antibiotic in 1948.
Emerging data suggests that more than 90% of Covid-19 patients are also receiving antibacterial treatment. It increases threat of drug-resistance bacteria.
The history of developing treatments and vaccines for two deadly coronaviruses — Ebola & Zika — isn't encouraging and there’s no guarantee COVID-19 will be different.
For the last 11 years, Nehru has been constantly blocking my efforts and causing the fiascos that are my many yojanas and abhiyans. He is the reason most of my initiatives turn into disasters.
India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
India should take up the issue in WTO to prevent the Chinese to arbitrarily play with the supply prices with an intent to impact our domestic prices as also our ability to export. This is totally against the principles of free trade which is based on demand supply dynamics. Simultaneously we should scout alternative supply lines until we become self reliant.
India should take up the issue in WTO to prevent the Chinese to arbitrarily play with the supply prices with an intent to impact our domestic prices as also our ability to export. This is totally against the principles of free trade which is based on demand supply dynamics. Simultaneously we should scout alternative supply lines until we become self reliant.
When a nation is 70% dependent on imports off API’s it’s a clear indication that policies and incentives for indigenous production have been very poorly managed . Certainly, it is not possible or practical to produce 100% of all ingredients and chemicals , but being able to make only 30% is a failure
Excerpt: “…. indicates positive interaction of ivermectin with viral protein targets, which is leading for SARS-CoV 2 N-protein NTD (nucleocapsid protein N-terminal domain).”
India should take up the issue in WTO to prevent the Chinese to arbitrarily play with the supply prices with an intent to impact our domestic prices as also our ability to export. This is totally against the principles of free trade which is based on demand supply dynamics. Simultaneously we should scout alternative supply lines until we become self reliant.
India should take up the issue in WTO to prevent the Chinese to arbitrarily play with the supply prices with an intent to impact our domestic prices as also our ability to export. This is totally against the principles of free trade which is based on demand supply dynamics. Simultaneously we should scout alternative supply lines until we become self reliant.
When a nation is 70% dependent on imports off API’s it’s a clear indication that policies and incentives for indigenous production have been very poorly managed . Certainly, it is not possible or practical to produce 100% of all ingredients and chemicals , but being able to make only 30% is a failure
Ivermectin was a potential drug in Covid-19, thus explaining its price increase. See: https://pubmed.ncbi.nlm.nih.gov/33389725/
Excerpt: “…. indicates positive interaction of ivermectin with viral protein targets, which is leading for SARS-CoV 2 N-protein NTD (nucleocapsid protein N-terminal domain).”
(I am an author in the paper)